Wound care · African market evaluation
MDM Wound Ventures
Country Intelligence supporting market-entry assessment across West and East African markets, including Mali, Kenya and Nigeria.
GHMAP product slides: Distributor Search, Country Intelligence, and Clinical Adoption Intelligence.
A vetted distributor shortlist for your product — in your target country.
GHMAP delivers 10–15 screened distributors, detailed assessments, and introductions for one MedTech or IVD product in one country. From $7,500 — request-first, no payment until scope is agreed in writing.
Illustrative visualization of two connected data systems — example only, not a partner network claimProfessional review is required before business use. GHMAP is not clinical decision support and does not guarantee regulatory approval, reimbursement, or market entry.
Country Intelligence delivered for
Wound-care market-entry work across Mali, Kenya and Nigeria.
Then the evidence.
Reviewed intelligence for one healthcare or MedTech product in one target country.
Scope lock · Decision instrument
ScopeLock
POCT blood-gas analyzer Türkiye
One product. One country. The scope is set, the evidence bar is fixed, and the named decision is locked before market entry begins.
“The GHMAP brief gave us a clear, evidence-based read on regulatory and distributor realities in West Africa before we committed our commercial budget. It is a critical tool for any MedTech team evaluating new markets.”
Where do you want to take your product?
Choose a product category, target country, and commercial objective. GHMAP uses this context to start the right request conversation.
Early work, real markets.
Country Intelligence delivered for wound-care companies evaluating entry into African markets.
Advanced wound care · International distribution planning
MELYVERA
Country Intelligence for a professional wound-care range preparing for international distribution, with focus markets in Africa.
“GHMAP provided the structured roadmap we needed to navigate international distribution for our advanced wound-care range. The source-tagged intelligence removed the guesswork from our expansion strategy.”
Choose the market-access decision in front of you.
Locked, request-first engagements for one healthcare or MedTech product in one target country.
Full Country Intelligence
For companies deciding whether and how to enter a specific healthcare market.
$5,000 · one product · one country
- Market opportunity
- Competitor & pricing intelligence
- Regulatory & reimbursement intelligence
- Buyer & procurement intelligence
Distributor Search & Qualification
For companies that understand their market but need an evidence-based partner landscape.
$7,500 · one product · one country
- Up to 30 screened candidates
- Up to 10 detailed assessments
- 3–5 recommended for outreach when evidence supports it
- Product, channel, conflict, and local-role context
Both offers are request-first and subject to scope review. Professional review is required before business use.
A clear path before deeper platform detail.
GHMAP organizes the questions, evidence, and commercial relationships around one expansion objective.
- 01Your product
- 02Target country
- 03Intelligence
- 04Qualified partners
- 05Market entry
- 06Commercialization
Grounded in real markets. Subject to professional review.
GHMAP organizes country context, pathway questions, and source status for international healthcare market access. Illustrative material is labeled. Professional review is required before business use.
Learn how we work →
Illustrative. Not a claim about a specific market outcome.
Market access is not only a data problem. It is also a relationship problem.
GHMAP connects product and country context to the people, organizations, projects, and decisions that shape responsible market-entry work.
- Manufacturer
- Product
- Country
- Regulatory Pathway
- Distributor
- Hospital
- HCP
- Project
- Meeting
- Decision
- Commercialization
Connected infrastructure for international expansion.
GHMAP is not simply producing isolated reports. It connects market-access work across the commercial journey.
- Intelligence
- Relationships
- Projects
- Meetings
- Decisions
- Commercialization
Where do you want to take your product?
Set the product, country, and objective. GHMAP reviews the context and confirms the appropriate next conversation.
Do not submit patient data, medical records, passwords, bank details, or confidential contracts.
Public photographs and visualizations are illustrative unless identified as REAL platform registry data. GHMAP is not clinical decision support and does not provide diagnosis, treatment, legal, regulatory, reimbursement, or investment advice. Professional review and source verification are required before business use. See the disclaimer.